Best-In-Class Hardware
Using the latest advancements in hardware and computing technology, our OEC testing instrument aims to provide faster results in a more portable, simpler, and user-friendly format*.
OxyDial’s new OEC test instrument, still under development and testing, leverages state-of-the-art hardware and a custom-built cloud platform, aiming to deliver the fastest, simplest, and most portable Oxygen-Hemoglobin testing instrument in the industry.
Strives to exceed current stationary lab equipment by 10x*
Aims to be 2x times faster than the closest competitor*
Potential to require just one drop of blood, enabling possibilities for pediatric studies*
Aims to require no instrument calibration or messy blood preparation*
Our cloud platform is designed with features to integrate seamlessly with clinical trial systems and consolidate studies from any testing location*
Aspires to allow for clinical trials in remote areas across the globe due to its small size and lightweight construction*
*These attributes are projected outcomes based on current testing, and have not yet been approved or validated by the FDA.
OxyDial was created to help push boundaries - to improve and expand critical healthcare for those who need it most, to accelerate and streamline the pace of medical research, and to explore the limits of what the human body can do. In particular, we focus on leveraging our technology in order to help improve the lives of those afflicted with genetic diseases and blood disorders like Sickle Cell Disease.
A core method for understanding and tracking blood test results, the Oxygen-Hemoglobin Equilibrium Curve enables medical professionals to understand the relationship between the amount of oxygen in your blood and the amount of hemoglobin capable of binding to that oxygen.
This helps determine how much oxygen can be delivered to the tissues in your body, and is critically important for diagnosing many medical conditions like anemia and pulmonary diseases.
Frequent calibration and ongoing cleaning and maintenance to remain operable.
A single test takes a minimum of 30 minutes to process, due to the long oxygenation and deoxygenation period.
50-100 uL of blood for a single test, making it unsuitable for infants and inapplicable for animal testing.
Inefficient software limits the ability to collect data, integrate with other systems, and can cause data loss.
Currently-available OEC blood testing devices have several shortcomings as a result of the lack of major development or advancement in the last two decades – the devices are heavy and hard to calibrate, and are both imprecise and slow to provide results.
Striving to deliver unique capabilities and enhancements to our clients, our team is continuously exploring and testing innovative technologies across the OxyDial platform and device.
Using the latest advancements in hardware and computing technology, our OEC testing instrument aims to provide faster results in a more portable, simpler, and user-friendly format*.
Our purpose-built cloud platform is designed for seamless integration with external systems while enabling automatic upload and storage of collected data from across the globe*.
We believe in providing exceptional support to our clients. Our ambition is to deliver world-class care and support at every stage of our partnerships, ensuring a customer-centric approach as we continue our testing and development process*.
*These features and customer service goals are based on ongoing tests and have not yet been validated or approved by the FDA.
Stay up-to-date with our latest blog posts, industry news, and important updates.